APA Citatie

Jinawath, N., Vasoontara, C., Yap, K., Thiaville, M. M., Nakayama, K., Wang, T., & Shih, I. (2009). NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.

Chicago Style citaat

Jinawath, Natini, Chanont Vasoontara, Kai-Lee Yap, Michelle M. Thiaville, Kentaro Nakayama, Tian-Li Wang, en Ie-Ming Shih. NAC-1, a Potential Stem Cell Pluripotency Factor, Contributes to Paclitaxel Resistance in Ovarian Cancer Through Inactivating Gadd45 Pathway. 2009.

MLA citatie

Jinawath, Natini, et al. NAC-1, a Potential Stem Cell Pluripotency Factor, Contributes to Paclitaxel Resistance in Ovarian Cancer Through Inactivating Gadd45 Pathway. 2009.